Document is current

Article History

Received: 18 March 2025

Accepted: 19 May 2025

First Online: 24 June 2025

Declarations

:

: Wilson Liao is an Editorial Board member of Dermatology and Therapy. Wilson Liao was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The author(s) disclosed receipt of the following financial support: Tina Bhutani has received research funding from Amgen, Castle, CorEvitas, Novartis, Pfizer, and Regeneron. She has served as an advisor for Abbvie, Arcutis, Aslan, Boehringer-Ingelheim, Bristol Myers Squibb, Dermavant, Galderma, Incyte, Janssen, Leo, Lilly, Pfizer, Novartis, Sanofi, Sun, Takeda, and UCB. She is a speaker for Janssen. Wilson Liao has received research grant funding from Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. All other authors (Andrea Leung, Kathryn Haran, Georgia Marquez-Grap, Kristen Chang, Chandler E Johnson, and Allison Kranyak) report no conflicts of interest.

: This study was approved by the institutional review board at the University of California, San Francisco (IRB# 22-36241). This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. All subjects provided informed consent to participate in this study. No identifiable information is included in this manuscript.